Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 4 Grant or award CEO & Chief Science Officer acquired 263,901 shares (grant or award)
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 4 Gift Director gave 350 shares (gift)
  7. 3/A Insider 3/A
  8. 4/A Insider Changes in Ownership
  9. 4/A Open-market sale CEO & Chief Science Officer sold 160,495 shares at an average $16.23 ($2,605,207)
  10. 4 Open-market sale EVP, Production sold 772 shares at $14.29 ($11,032)
  11. 4 Open-market sale Director sold 30,770 shares at an average $14.20 ($436,853)
  12. 4 Open-market sale Director sold 30,770 shares at an average $14.19 ($436,719)
  13. 4 Open-market sale Director sold 38,462 shares at an average $14.34 ($551,599)
  14. 4 Open-market sale 10% owner sold 63,300 shares at an average $14.25 ($901,753)
  15. 4 Open-market sale CEO & Chief Science Officer sold 63,300 shares at an average $14.25 ($901,753)
  16. 4 Open-market sale 10% owner sold 68,117 shares at an average $14.71 ($1,001,909)
  17. 4 Open-market sale CEO & Chief Science Officer sold 68,117 shares at an average $14.71 ($1,001,909)
  18. 4 Open-market sale 10% owner sold 38,583 shares at an average $15.45 ($596,241)
  19. 4 Open-market sale CEO & Chief Science Officer sold 38,583 shares at an average $15.45 ($596,241)
  20. 4 Open-market sale Director sold 31,529 shares at $14.29 ($450,512)

Page 42 of 48 · 958 filings